Advertisement

Topics

Companies Related to "Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure" [Most Relevant Company Matches] - Page: 5 RSS

09:10 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Efficacy Atrasentan With Hormone Naive Prostate Cancer" Companies 101–125 of 4,000+

Relevant

Cyterix Pharmaceutics, Inc.

Cyterix Pharmaceutics, Inc., a privately held cancer therapeutics company, is engaged in the discovery and development of new classes of small molecule prodrugs with improved safety and efficacy over traditional drugs. The company’s approach, based on a proprietary technology platform, uniquely enables the design of multiple classes of anticancer p...


Zelos Therapeutics Inc.

Zelos Therapeutics is an emerging private biopharmaceutical development company that is commercializing breakthrough discoveries in parathyroid hormone (PTH) research. The company is developing medications for the treatment of osteoporosis, psoriasis and for enhancing engraftment following stem cell transplantation. During 2005, Zelos Therapeutics experienced a number of significant milestones. Ke...

IFM Therapeutics

IFM Therapeutics is a privately held biopharmaceutical company based in Boston, Massachusetts. The company was founded in 2015 by an international group of preeminent scientists and physicians who have spent decades understanding innate immunity and the role it plays in regulating the immune system. IFM’s team has discovered and developed small molecu...


Genexine, Inc.

Genexine, Inc., listed on KOSDAQ (095700) since 2009, is a leading biotherapeutics company focused on immuno-oncology and orphan disease. Genexine has robust pipelines in clinical and pre-clinical stages based on long-acting Fc fusion technology and therapeutic DNA technology. In the clinical stage, Genexine has GX-H9 (long-acting human growth hormone, hGH...

GTx, Inc. and Ipsen

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways to prevent and treat cancer, fractures and bone loss, muscle loss and other serious medical conditions. For more information on GTx, visit our website, www.gtxinc.com....

Cell Works Incorporated

Cell Works Inc. is an early-stage biomedical company located in Baltimore, Maryland, basing their initial products on research conducted at The Johns Hopkins University (JHU). Cell Works has exclusively licensed certain cell isolation technology from JHU on a worldwide basis. This technology license currently incorporates one patent, one patent application, and related international patent applica...

NuCana

NuCana® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Company’s proprietary ProTide technology has the potential to set new benchmarks in efficacy and safety with its treatments that are specifically designed to overcome key cancer resistance mechanisms. Acelari...

Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc. is developing next generation therapeutic vaccines for the treatment of cancer and infectious diseases. The company's pharmacologically regulated DeCIDe(TM) vaccines are designed to kill targeted cells by inducing a potent, durable, fully activated antigen-specific TH1 immune response. Lead product BPX-101, an autologous DeCIDe(TM) vaccine, is in clinical development...

PURE Bioscience

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's ...

Seattle Prostate Institute

The Seattle Prostate Institute was established in 1997 by a group of physicians who, in the mid-1980's, had pioneered the introduction and development of ultrasound-guided prostate implantation in the United States from their base at Seattle's Northwest Hospital. After relocating to Swedish Medical Center, another of the city's premier institutions, these physicians sought to expand and improve up...

Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc.

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the le...

Innocrin Pharmaceuticals, Inc.

Innocrin discovers and develops novel, best-in-class oral inhibitors of CYP17 lyase, a validated enzyme target for the treatment of castration-resistant prostate cancer. VT-464 and the entire CYP17 inhibitor patent estate are wholly owned by Innocrin. CYP17 lyase inhibitors may also have high commercial potential for the treatment of breast cancer as we...

PharmaMar

PharmaMar is Grupo Zeltia's biotechnology subsidiary; it is a world leader in discovering, developing and selling marine-based drugs to treat cancer. Yondelis(R) is Spain's first anti-cancer drug. It is currently approved for soft tissue sarcoma (STS) in 25 countries outside the EEA, and in 5 of those countries for platinum-sensitive recurrent ovarian cancer (ROC) as well. Yondelis(R) is approved ...

Kanzius Cancer Research Foundation

The Kanzius Cancer Research Foundation is a 501(c)(3) non-profit organization with a mission to create national and global awareness of the potentials of the Kanzius Noninvasive Radiowave Cancer Treatment, and to help accelerate the speed at which this research progresses to human trials. The goal of KCRF is to raise money to support ongoing research grants. Pancreatic, liver and colorectal cance...

Fans For The Cure

Ed Randall's Fans For The Cure was founded in 2002 after the charity’s founder, Ed Randall, was diagnosed with prostate cancer. After treatment at St. Luke’s-Roosevelt Hospital, Ed's cancer went into, and remains, in remission. Ed Randall is the host of Ed Randall’s Talking Baseball on Sirius/XM Radio Channel 175 and WFAN Radio in New York. Heâ€...

Siamab Therapeutics, Inc.

Siamab Therapeutics, Inc. is a biopharmaceutical company developing novel cancer immunotherapies targeting cancer-specific carbohydrate antigens seen in multiple solid tumors. Siamab has developed a platform that enables the rapid discovery and development of therapeutic antibodies that bind with unprecedented specificity and affinity to this novel class o...

Movember

Movember is a global charity event that invites men to grow moustaches (or Mos) for the month of November. The moustache serves as the 'ribbon' and the vehicle by which participants in Movember raise funds and awareness for men's health - specifically prostate and testicular cancer. Movember aims to reduce the number of preventable male deaths by raising funds and creating awareness for cancer a...

IrriMax Corporation

Founded in 1994, IrriMax® Corporation develops and markets wound irrigation solutions using a patented, innovative delivery method that produces unmatched efficacy and safety. The medical device company’s goal is to improve patient outcomes by treating and preventing infections, as well as to increase the safety of healthcare workers. Its flagship ...

Optivia Biotechnology Inc.

Based in Menlo Park, CA, Optivia Biotechnology, Inc. is a leader in developing and providing comprehensive in vitro transporter assay services to help in the discovery and development of drugs with improved safety and efficacy. Optivia uses its proprietary Opti-ExpressionTM technology to create transporter assays that more closely model human biology, and ...

Matritech

Matritech, Inc. develops, manufactures and markets innovative cancer diagnostic products based on its proprietarynuclear matrix protein ("NMP") technology. The nuclear matrix, a three dimensional protein framework within the nucleus of cells, plays a fundamental role in determining cell type by physically organizing the contents of the nucleus, including DNA. The Company has demonstrated that th...

Unum Therapeutics

Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming months to assess safety and effi...

Prostate Awareness Research Foundation

The Prostate Awareness Research Foundation (PAR for Life) is in the process of becoming a national registered 501(c)(3) nonprofit foundation. PAR for Life was established in late 2009 as a charitable organization in the state of Oregon.

MacuSight, Inc.

MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part...

Lumicell, Inc.

Lumicell is a leader in the field of image-guided cancer surgery. The company is developing a revolutionary intraoperative imaging system that gives surgeons real-time visual feedback of residual cancer in the tumor bed. Lumicell’s surgical system includes a margin-targeted injectable imaging agent and a novel hand-held imaging device with exquisite s...

STATE INSTITUTE FOR DRUG CONTROL

The State Institute for Drug Control (SIDC) in Bratislava is the institution of the Ministry of Health of the Slovak Republic responsible for ensuring surveillance of the quality, efficacy and safety of medicinal products for human use and medicinal products used in health care. In accordance with the laws SIDC, among other things, has SIDC the following responsibilities: - controls, standardizes ...


More From BioPortfolio on "Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks